window._izq.push ([“userProfile”, {“add”: {
“Category”: “News”
}
}]);

# dailymotion-pip-small-viewport {
above: 125px! important;
}
# dailymotion-pip-large-viewport {
left: 0px! important;
right: auto! important;
below: 140px! important;
} (Function (a, c, s, u) {‘Insticator’in a || (a.Insticator = {ad: {loadAd: function (b) {Insticator.ad.q.push (b)}, q: []}, helper: {}, embed: {}, version: “4.0”, q: [], load: function (t, o) {Insticator.q.push ({t: t, o: o}) }}); var b = c.createElement (s); b.src = u; b.async =! 0; var d = c.getElementsByTagName (s) [0]; d.parentNode.insertBefore (b, d) }) (Window, Document, ‘Script’, ‘//d3lcz8vpax4lo2.cloudfront.net/ads-code/7bfb7b00-638d-4331-aa02-1a00de86d835.js’)
@media (max-width: 767px) {
.wp-pagenavi {justify-content: normal! important;}

}
# ctcg_frame_65349_0 {display: none;}
#mc_embed_signup .mc-field-group select {padding: 14px 4px! important;}
.mc-field-group.input-group strong {margin-top: 8px;}
.article-header .share-count .share-it {display: none! important;}
.share.counter {display: none;}
.a2a_dd .a2a_count {display: none! important;}
.article-header .share-count .a2a_dd {justify-content: space-around! important;}
! function (c, h, i, m, p) {m = c.createElement (h), p = c.getElementsByTagName (h) [0], m.async = 1, m.src = i, p.parentNode .insertBefore (m, p)} (document, “script”, “https://chimpstatic.com/mcjs-connected/js/users/96b88e4b8fb304ba51edb006e/efc0ee07c1e8f769af549cd2e.js”); (function (w, sd) {var = d.createElement (‘script’); s.src = ‘//cdn.adpushup.com/41918/adpushup.js’; s.type = ‘text / javascript’; s.async = true; (d.getElementsByTagName ( ‘head’) [0] || d.getElementsByTagName (‘body’) [0]). appendChild (s);}) (window, document);

The controversial CEO of Pharmally Pharmaceuticals Corporation, Krizle Grace Mago , vowed Tuesday, September 28, to do its best to “continue to cooperate” with the ongoing Congressional investigation into allegedly inflated prices for its company’s COVID-19 shipments to the government.

In a The statement released to the media, Mago dispelled fears for her welfare and said that she was neither missing nor went into hiding.

“H umihingi po ako ng pasensya kung gnaw out of reach po ako ng ilang araw. Kianakailangan ko lang po i-proseso ang lahat ng nangyayari (I apologize if I’ve been out of reach for several days. I just have to process everything that happened), ”she said.

Mago, Head of Regulatory Affairs at Pharmally said she was in a difficult and pressured position as a result of ongoing legal investigations.

“Pero gusto ko ring malaman ng lahat na (I want everyone to know too) I was never told by anyone at Pharmally threatened, “stressed Mago.

She also assured:” I will do my best to continue to cooperate for the duration of this investigation. “

Mago has not received any calls since she reportedly received the offer of protection from the Senate agreed so that she can continue to testify before the Blue Ribbon Committee hearings.

It is worth recalling that the Pharmally executive admitted to members of the Senate Blue Ribbon that they had expired face shields attached to the Health Department.

The face shields and face masks procured by Pharmally’s Budget Management Procurement Services division were reportedly overpriced.

Mago’s statement was described as a turning point in the Senate’s drive to address reported anomalies in Pharmally’s dealings with the government.

The Senate has asked the National Bureau of Investigation for help in finding Mago. A subpoena has been issued for them.

The House of Representatives Good Government Committee has also issued a subpoena for the “missing” Pharmally officials to appear in the continuation of a parallel investigation into the inflated pricing issue. </ Senators have attacked the good government body chaired by DIWA partylist Rep. Michael Edgar Aglipay for allegedly pursuing its investigation to divert public attention from Duterte government officials suspected of pharmallly cheating to defrauding the government of billions of pesos in public funds.

Aglipay brushed the allegations aside, saying that the House of Commons, like the Senate, wants to know the truth about the controversy surrounding the DOH and the PS-DBM.

Ref: https://mb.com.ph